Clinical Trials Directory

Trials / Completed

CompletedNCT03037918

Effect of Yakult Ingestion on Diet-induced Insulin Resistance in Humans

Effect of Yakult Ingestion on Diet-induced Insulin Resistance in Humans. A Large-cohort, Mechanistic Follow-up Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Loughborough University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Participants will be randomly allocated to either Yakult ingestion or a control group. For the first 20 days, subjects will consume their normal diet (keeping a detailed food diary throughout). On days 21-28 they will switch to a high-fat/high-calorie diet. The investigators hypothesise that consuming a high-fat, high-energy diet for 7 days will alter the composition of the gut microbiota and induce metabolic endotoxaemia / systemic inflammation as well as decreasing whole body insulin sensitivity (as we have shown previously). In contrast, the investigators hypothesise that consuming Yakult for 21 days before and 7 days throughout the high-fat diet will maintain a favourable gut microbiota and prevent metabolic endotoxaemia / systemic inflammation and thus maintain insulin action / insulin sensitivity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTYakult lightA fermented milk drink containing the probiotic Lactobacillus casei Shirota

Timeline

Start date
2017-02-03
Primary completion
2018-08-31
Completion
2018-08-31
First posted
2017-01-31
Last updated
2018-10-31

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03037918. Inclusion in this directory is not an endorsement.